Clinical trialNCT03877536WithdrawnInterventional

Antiretroviral Therapy for Acute HIV Infection

SponsorHenry M. Jackson Foundation for the Advancement of Military MedicineEnrollment0HIV Infections

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study will evaluate the virologic effect, safety and tolerability of Genvoya® in adults during early acute HIV infection.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Christina Polyak, MD, MPH
Henry M. Jackson Foundation in support of MHRP
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Uganda

Makerere University--Walter Reed Project (muwrp)
Kampala, Uganda

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Genvoya 150Mg-150Mg-200Mg-10Mg Tablet

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Mar 2019
Primary completion: 14 Sept 2023
Completion: 14 Sept 2025
Last update posted: 26 Apr 2019
Registered enrollment: 0
Registry id: NCT03877536

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.